Astellas Pharma opens a new state-of-the-art life sciences facility to expand its R&D footprint in order to accelerate innovation and deliver VALUE to patients.
The new facility is set to utilise two floors encompassing approximately covering 62,000 square feet.
This facility will accommodate both laboratory and office spaces to house the discovery accelerator.
The facility will become the operational hub for several diverse functions including medical & development, business development, and research.
This investment stands as a testament to enduring growth in the Greater Boston vicinity, as well as its endeavour to foster novel centres of innovation and synergy.
The forthcoming establishment will foster a harmonious environment, facilitating seamless collaboration to harness the wide-ranging expertise both within the organisation and beyond its confines.
The upcoming facility is anticipated to open in 2024.
Name Astellas Pharma
Type New Construction